دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Obesity in China: time to act
doi : 10.1016/S2213-8587(21)00150-9
VOLUME 9, ISSUE 7, P407, JULY 01, 2021
Obesity: what's in a word?
David E Cummings,Francesco Rubino
doi : 10.1016/S2213-8587(21)00122-4
VOLUME 9, ISSUE 7, P408-409, JULY 01, 2021
Nitisinone: two decades treating hereditary tyrosinaemia type 1
Wendy J Introne
doi : 10.1016/S2213-8587(21)00121-2
VOLUME 9, ISSUE 7, P409-411, JULY 01, 2021
Cognitive decline in longstanding type 1 diabetes: a role for severe hypoglycaemia
Brian M Frier
doi : 10.1016/S2213-8587(21)00117-0
VOLUME 9, ISSUE 7, P411-412, JULY 01, 2021
Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK
Matthew J Carr,Alison K Wright,Lalantha Leelarathna,Hood Thabit,Nicola Milne,Naresh Kanumilli,Darren M Ashcroft,Martin K Rutter
doi : 10.1016/S2213-8587(21)00116-9
VOLUME 9, ISSUE 7, P413-415, JULY 01, 2021
An Pan: A life-course perspective
Carl Power
doi : 10.1016/S2213-8587(21)00140-6
VOLUME 9, ISSUE 7, P416, JULY 01, 2021
First, do no harm
Jennifer Thorley
doi : 10.1016/S2213-8587(21)00146-7
VOLUME 9, ISSUE 7, P417, JULY 01, 2021
European Commission classifies obesity as a chronic disease
Talha Burki
doi : 10.1016/S2213-8587(21)00145-5
VOLUME 9, ISSUE 7, P418, JULY 01, 2021
Correction to Lancet Diabetes Endocrinol 2021; 9: 373–92
doi : 10.1016/S2213-8587(21)00149-2
VOLUME 9, ISSUE 7, E2, JULY 01, 2021
Correction to Lancet Diabetes Endocrinol 2021; 9: 393–405
doi : 10.1016/S2213-8587(21)00148-0
VOLUME 9, ISSUE 7, E2, JULY 01, 2021
Correction to Lancet Diabetes Endocrinol 2021; 9: 419–26
doi : 10.1016/S2213-8587(21)00151-0
VOLUME 9, ISSUE 7, E2, JULY 01, 2021
Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study
Rishi Caleyachetty,Thomas M Barber,Nuredin Ibrahim Mohammed,Francesco P Cappuccio,Rebecca Hardy,Rohini Mathur,Amitava Banerjee,Paramjit Gill
doi : 10.1016/S2213-8587(21)00088-7
VOLUME 9, ISSUE 7, P419-426, JULY 01, 2021
Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study
Ute Spiekerkoetter,Maria L Couce,Anibh M Das,Corinne de Laet,Carlo Dionisi-Vici,Allan M Lund,Manuel Schiff,Marco Spada,Erik Sparve,Johan Szamosi,Roshni Vara,Mattias Rudebeck
doi : 10.1016/S2213-8587(21)00092-9
VOLUME 9, ISSUE 7, P427-435, JULY 01, 2021
Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT and EDIC Study
Alan M Jacobson,Christopher M Ryan,Barbara H Braffett,Rose A Gubitosi-Klug,Gayle M Lorenzi,José A Luchsinger,Victoria R Trapani,Ionut Bebu,Naomi Chaytor,Susan M Hitt,Kaleigh Farrell,John M Lachinthe DCCT/EDIC Research Group
doi : 10.1016/S2213-8587(21)00086-3
VOLUME 9, ISSUE 7, P436-445, JULY 01, 2021
Health policy and public health implications of obesity in China
Youfa Wang,Li Zhao,Liwang Gao,An Pan,Hong Xue
doi : 10.1016/S2213-8587(21)00118-2
VOLUME 9, ISSUE 7, P446-461, JULY 01, 2021
Towards unified and impactful policies to reduce ultra-processed food consumption and promote healthier eating
Barry M Popkin,Simon Barquera,Camila Corvalan,Karen J Hofman,Carlos Monteiro,Shu Wen Ng,Elizabeth C Swart,Lindsey Smith Taillie
doi : 10.1016/S2213-8587(21)00078-4
VOLUME 9, ISSUE 7, P462-470, JULY 01, 2021
